Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Albumin and bleed risk in rivaroxaban treated patients
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Albumin and bleed risk in rivaroxaban treated patients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rivaroxaban
100%
Albumin
100%
Bleed Risk
100%
Albumin Level
55%
Bleeding Events
44%
Protein Binding
22%
Multivariable Logistic Regression Model
22%
Adjusted Odds Ratio
11%
Retrospective Cohort Study
11%
High Protein
11%
Hemoglobin
11%
Clinical Effect
11%
Hypoalbuminemia
11%
Hospitalized Adults
11%
Mean Standard Deviation
11%
Bleeding
11%
Low Albumin
11%
High Bleeding Risk
11%
95% Confidence Interval
11%
Pharmacology, Toxicology and Pharmaceutical Science
Rivaroxaban
100%
Ciclonicate
100%
Albumin
100%
Bleeding
33%
Protein Binding
11%
Cohort Study
11%
Hypoalbuminemia
11%
Hemoglobin
11%